Form 4 BeiGene, Ltd. For: Feb 28 Filed by: BAKER JULIAN

Go back to Form 4 BeiGene, Ltd. For: Feb 28 Filed by: BAKER JULIAN

JPMorgan Reiterates Overweight Rating on BeiGene Ltd. (ONC), PT $311

March 3, 2025 4:19 PM EST

JPMorgan analyst Jessica Fye reiterated an Overweight rating and $311.00 price target on BeiGene Ltd. (NASDAQ: ONC)

The analyst comments "We hosted a call with mgmt and investors following ONCs strong 4Q print and 2025 guide. The conversation touched on the various factors associated with 2025... More